RNPC3 and depressive symptom measurement: The study did not demonstrate an association between systemic sclerosis-specific autoantibodies (i.e., anti-centromere antibodies (ACA), anti-Scl-70, anti-polymerase III or anti-RNP) and the risk of depression in patients with scleroderma.